BiotechTubeBiotechTube
Home/Roivant Sciences/Daniel Gold
DG

Daniel Gold

Director

Roivant Sciences

Therapeutic Areas

Autoimmune DiseasesRare DiseasesPulmonary DiseasesDermatologyOphthalmology

Roivant Sciences Pipeline

DrugIndicationPhase
BrepocitinibDermatomyositisRegistrational
IMVT-1402Graves' DiseaseRegistrational
BatoclimabThyroid Eye DiseaseProof of Concept
MosliciguatPulmonary Hypertension associated with Interstitial Lung DiseaseProof of Concept
VTAMA (tapinarof)Plaque PsoriasisCommercial

Leadership Team at Roivant Sciences

MG
Matt Gline
Chief Executive Officer
MG
Matt Gline
Director
AG
Alex Gasner
Executive Vice President, Roivant Health
EV
Eric Valeur
Vice President, Head of Drug Discovery
View full Roivant Sciences profile